6-156778268-CCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001374828.1(ARID1B):​c.609_611delGCA​(p.Gln204del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,522,410 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00042 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00030 ( 0 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.26

Publications

5 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778268-CCAG-C is Benign according to our data. Variant chr6-156778268-CCAG-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 589060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000423 (64/151330) while in subpopulation AFR AF = 0.000509 (21/41284). AF 95% confidence interval is 0.00034. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 64 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.609_611delGCA p.Gln204del disruptive_inframe_deletion Exon 1 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.609_611delGCA p.Gln204del disruptive_inframe_deletion Exon 1 of 20 2 NM_001374828.1 ENSP00000490491.2

Frequencies

GnomAD3 genomes
AF:
0.000423
AC:
64
AN:
151216
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000510
Gnomad AMI
AF:
0.00771
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000384
Gnomad OTH
AF:
0.000962
GnomAD2 exomes
AF:
0.000842
AC:
109
AN:
129416
AF XY:
0.000777
show subpopulations
Gnomad AFR exome
AF:
0.000773
Gnomad AMR exome
AF:
0.000611
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000425
Gnomad FIN exome
AF:
0.00400
Gnomad NFE exome
AF:
0.000752
Gnomad OTH exome
AF:
0.000527
GnomAD4 exome
AF:
0.000295
AC:
405
AN:
1371080
Hom.:
0
AF XY:
0.000288
AC XY:
195
AN XY:
676282
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000580
AC:
18
AN:
31028
American (AMR)
AF:
0.000315
AC:
11
AN:
34904
Ashkenazi Jewish (ASJ)
AF:
0.0000808
AC:
2
AN:
24744
East Asian (EAS)
AF:
0.000172
AC:
6
AN:
34928
South Asian (SAS)
AF:
0.000207
AC:
16
AN:
77214
European-Finnish (FIN)
AF:
0.00151
AC:
62
AN:
41042
Middle Eastern (MID)
AF:
0.00127
AC:
7
AN:
5530
European-Non Finnish (NFE)
AF:
0.000252
AC:
268
AN:
1064670
Other (OTH)
AF:
0.000263
AC:
15
AN:
57020
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.361
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000423
AC:
64
AN:
151330
Hom.:
0
Cov.:
30
AF XY:
0.000324
AC XY:
24
AN XY:
73974
show subpopulations
African (AFR)
AF:
0.000509
AC:
21
AN:
41284
American (AMR)
AF:
0.000394
AC:
6
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5104
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4790
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10502
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000384
AC:
26
AN:
67658
Other (OTH)
AF:
0.000952
AC:
2
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
0
Bravo
AF:
0.000355

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 28, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1B-related disorder Benign:1
Mar 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Inborn genetic diseases Benign:1
Mar 29, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Coffin-Siris syndrome 1 Benign:1
Dec 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.3
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779743; hg19: chr6-157099402; COSMIC: COSV51650063; COSMIC: COSV51650063; API